Clinical Data Expects to Gross $66M in Public Stock Offering

Jul 18, 2007

NEW YORK (GenomeWeb News) — Clinical Data expects to gross $66 million in a previously disclosed plan to offer 3 million shares of its common stock. The offering would price the shares at $22 apiece, the company said today.

Clinical Data plans to pump some of the proceeds into clinical trials, preclinical R&D, and expenses, acquisitions, and working capital.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

The Same Genes Keep Getting Asked to Prom

Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.

Keep Them in the Know

The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.

From Tusk to Cartel

Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.

This Week in Nature

In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.

Main menu